Preclinical efficacy and cellular mechanisms of a polyherbal formulation in doxorubicin nephrotoxicity: PRECLINICAL SAFETY AND EFFICACY OF A POLYHERBAL FORMULATION. IJTK [Internet]. 2025 Jan. 17 [cited 2026 May 13];24(1):33-41. Available from: https://or.niscpr.res.in/index.php/IJTK/article/view/5664